John Hancock Offers Discounted Prenuvo Whole-Body MRI Scans, a First in the Life Insurance Industry

John Hancock Offers Discounted Prenuvo Whole-Body MRI Scans, a First in the Life Insurance Industry
John Hancock, a unit of Toronto-based Manulife, announced today that it is the first life insurer in the U.S. to offer discounted access to Prenuvo's state-of-the-art whole-body MRI scans to eligible John Hancock Vitality customers. 

The Prenuvo whole body scan currently retails for $2,499 and is not covered by health insurance.

John Hancock Vitality members will now receive a $500 discount on Prenuvo’s whole-body scans. This industry-first offering underscores John Hancock’s commitment to providing customers with cutting-edge technology and screening tools, enabling them to take proactive steps in understanding and managing their health.

Middle Category Image

The initiative builds on John Hancock’s previous investments in proactive and preventative health measures. The company was also the first life insurer to offer access to GRAIL’s multi-cancer early detection test, Galleri, further solidifying its dedication to enhancing customer health and wellness.

“Early detection for cancer, lifestyle diseases, neurological diseases, and countless other health issues can make a world of difference for not just individuals and their families, but for society, our healthcare system, and our business,” said Brooks Tingle, president and CEO, John Hancock. “That’s why, at John Hancock, we’re committed to offering our customers access to emerging technologies that can help them take control of their health and hopefully drive better outcomes. We’re thrilled to bring Prenuvo’s visionary MRI technology to our customers.”

Data shows that six in 10 Americans live with a chronic illness, such as heart disease, cancer, diabetes, or other conditions. These represent one of the nation’s leading causes of disability and drivers of the nation’s annual health care spending. Prenuvo’s cutting-edge whole-body scan can identify 500+ conditions, including most solid tumors which can be detected as early as stage 1, in addition to aneurysms, cysts, and more.

“Out of the $4.5 trillion spent on healthcare in the US, less than 4% is allocated to preventative care. That needs to change,” said Andrew Lacy, CEO and founder of Prenuvo. “Our collaboration with John Hancock marks the first step towards making preventative healthcare more accessible to consumers, and we’re excited to expand this partnership in the future as part of our ongoing efforts to engage with the insurance industry.”

After receiving a scan, qualified John Hancock Vitality members will have the opportunity to review their report with a nurse practitioner arranged by Prenuvo. Individual reports will not be shared with John Hancock and will not impact a customer’s current life insurance coverage, pricing, or status in the John Hancock Vitality Program.

John Hancock Vitality is available with the company’s life insurance policies — offering education, support, incentives, and rewards to encourage customers to take everyday steps toward a longer, healthier, better life. John Hancock and Prenuvo hope to explore additional ways to expand the collaboration in the future.

Source: John Hancock

Bottom Category Image

Share this article: